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Compliance with Surgical Care Improvement Project
Blood Glucose—A Marker for Euglycemia,
but Does It Put our Patients at Risk?
Isaac R. Whitman, MD,1 Maura Murphy, BA,2 Marta M. Gilson, PhD,3 Amy Campfield, MD,4
Michel Haddad, MD,2 Elizabeth Moxey, MPH,2 and Glenn J.R. Whitman, MD 3

Abstract

To improve outcomes in open heart surgery (OHS) patients, the Surgical Care Improvement Project (SCIP)
requires 6 am postoperative day (POD) 1 and 2 blood glucose (BG) to be £ 200mg/dL. This study examined risk
factors for SCIP noncompliance when using an insulin infusion protocol (IIP) and evaluated this SCIP metric as a
surrogate for glycemic control. The authors divided 99 consecutive OHS patients, all subjected to 1 uniform IIP,
into 2 groups: Group 1–SCIP compliant (n = 79) and Group 2–SCIP noncompliant (n = 20). They determined
mean BG for the first 48 postoperative hours, percent of total time with hyperglycemia (% time BG > 200mg/dL)
for each group, and assessed risk of SCIP noncompliance as relates to multiple risk factors including intensity of
IIP application, and switching to subcutaneous (SQ) insulin prior to 6 am on POD 2. Group 1 had lower mean
BG than Group 2 and percent of total time with hyperglycemia, P < 0.0001. Multivariate analysis showed diabetes, obesity in nondiabetics, and switching to SQ insulin prior to 6 am on POD 2 to be risk factors for SCIP
noncompliance. The 6 am BG values on POD 1 or POD 2 each correlated with average postoperative BG, and
compliance with the SCIP BG metric was associated with virtually uniform BG £ 200mg/dL. IIP application was
not significantly different between groups (P = 0.2). Only patients who had been switched to SQ insulin prior to 6
am POD 2 were noncompliant at 6 am on POD 2. There were hypoglycemic events (BG < 70mg/dL) in 15 of 99
patients (15%), 12 of whom (80%) were in Group 1. Noncompliance with this SCIP measure occurred more
frequently in patients with diabetes or, if nondiabetic, in those patients with obesity. A trend toward increased
insulin assessments in the SCIP noncompliant group suggests that 1 uniform IIP for all patients may not be
effective. By not requiring the reporting of hypoglycemia, SCIP may inadvertently be exposing patients to harm.
(Population Health Management 2012;15:309–314)

Introduction

H

yperglycemia has been shown to be deleterious to
critically ill patients.1 Various studies have shown a direct relationship between hyperglycemia and infection, need
for renal replacement therapy, ventilatory support, blood
transfusion, and mortality in both the short and long term.2–4
More specifically, in postoperative cardiac surgery patients,
elevated blood glucose (BG) has been linked to increased incidence of deep sternal wound infections, all-cause infection
and sepsis, and mortality.5–9

As a result of the convincing data on the benefits of
glycemic control in postoperative cardiac surgery patients
and in an effort to improve adherence to evidence-based
guidelines, the Surgical Care Improvement Project (SCIP)
established reporting of 6 am BG levels on postoperative
days (POD) 1 and 2 for all cardiac surgery patients, requiring values of £ 200 mg/dL for compliance.10–12 In an
effort to meet SCIP standards and provide better care for
patients by more reliably controlling postoperative BG,
many hospitals have adopted intravenous (IV) insulin infusion protocols (IIP) rather than relying on subcutaneous
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(SQ) insulin, as IIPs appear to more reliably control blood
sugars.13,14
Justification for maintenance of euglycemia by SCIP centers
on the relationship of hyperglycemia to morbidity and mortality.15, 16 Interestingly, as solid as the evidence is for the
benefit of postoperative euglycemia in open heart surgery
patients, there appears no evidence that 2 randomly chosen
morning blood sugars reflect this degree of glycemic control.
To this point, the specific SCIP metric reported herein is based
on a theoretical relationship not addressed by the literature.
Our university hospital cardiac surgical program found
itself able to uniformly meet all SCIP reported metrics at the
top 10% of hospitals in the country except for BG control, for
which it was inexplicably at the 50th percentile. Confounded
by this, the authors hypothesized that the mediocre performance resulted from a failure to strictly implement our IIP;
specifically, that its utilization was inconsistent and BG assessments were not performed at the required frequency.
Secondly, given that the reporting of 6 am BG as a marker of
overall glycemic control had no justification in the literature,
the authors recognized that while testing that hypothesis,
they had the opportunity to address the question of whether
the SCIP metric of 6 am BG was, in fact, reflective of overall
glycemic control during the early postoperative period. They
specifically hoped that this single-center study might generate further hypotheses and research on this subject and the
subject of reported metrics in general.
Methods
Study design
The authors conducted a retrospective chart review of 140
consecutive postoperative heart surgery patients admitted to
the surgical cardiac care unit in our academic, quaternary
care hospital between September 1, 2007 and October 1, 2008.
Patients qualifying for the study had postoperative orders for
our hospital’s IIP. Patients were excluded if they were not
receiving insulin IV on POD 1 at 6 am, as the primary purpose of the study was to examine the reasons patients on an
IIP might fail to meet the SCIP metric. Furthermore, patients
who died prior to POD 2 or who had missing descriptive data
were excluded. This resulted in 99 eligible patients upon
whom this study was based. The change in the insulin infusion rate determined by the IIP algorithm involved both realtime BG level and the change in BG from the previous hour.
We used the capillary blood glucose sample reported in the
medical record for all data analysis as (a) SCIP utilizes this
manner of glucose measurement for its report, and (b) as
stated above, our protocolized insulin adjustments are based
on this measurement. BG was targeted at 80—140 mg/dL. The
decision to transition to insulin SQ on POD 1 was determined
by the attending. The insulin SQ regimen for each patient was
based on the quantity of insulin that the patient received over
the immediately previous euglycemic period, and followed
the guidelines of the American Diabetes Association.17
Evaluation of SCIP 6 am BG POD 1 and 2
as a surrogate of euglycemia
To evaluate the appropriateness of using ‘‘6 am BG on
POD 1 and 2’’ as a surrogate for glycemic control, the authors
compared the SCIP compliant group (Group 1, defined as
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those patients with BG £ 200 mg/dL at 6 am on both POD 1
and 2) to the SCIP noncompliant group (Group 2, defined as
those patients with BG > 200 mg/dL at 6 am on either POD 1
or 2). They examined each group’s average BG over the
measured 48-hour period, the number of episodes of BG
> 200 mg/dL, the percent time with BG > 200 mg/dL, and
performed a linear regression analysis to relate each patient’s
6 am BG with his or her average BG over the course of the
study period. The BG measurement taken closest to 6 am
was used as the 6 am BG, per the SCIP definition.
Total time of BG monitoring was defined as the first 48
postoperative hours, beginning with the time of the first BG
check on POD 0. Time with BG > 200 mg/dL (hyperglycemic) was determined such that if 1 BG measure was
> 200 mg/dL and the next measure was BG £ 200 mg/dL, the
entire time between measurements was viewed as hyperglycemic; when a BG was not hyperglycemic followed by
one that was, that interim period was viewed as not hyperglycemic. Hyperglycemic time was expressed as a percent of
the total time of BG monitoring. The authors additionally
counted both the number of hypoglycemic and hyperglycemic episodes, defined as any BG < 70 mg/dL and BG
> 200 mg/dL, respectively. However, if a patient met the
requirements for a hypoglycemic or hyperglycemic episode,
adjacent noneuglycemic values did not count as separate
episodes (ie, multiple adjacent BG > 200 mg/dL values did
not count as separate episodes).
Factors associated with SCIP compliance
Baseline patient and postoperative characteristics were
compared for Groups 1 and 2. The Fisher exact test was used
to compare categorical variables; continuous variables were
compared using the Kruskal-Wallis test.
Potential risk factors of SCIP noncompliance included age,
obesity, sex, epinephrine infusion, history of diabetes mellitus (DM), intensity of implementation of the IIP, defined as
number of assessments of the insulin infusion rate per hour,
and switching to insulin SQ prior to 6 am on POD 2. Logistic
regression was used to evaluate the relationship between
SCIP noncompliance and these potential risk factors. Additionally, we compared those patients who transitioned to
insulin SQ prior to 6 am on POD 2 versus those who remained on the IIP through 6 am on POD 2.
As a point of clarification, the number of BG assessments
per hour while on the IIP was used as a marker for intensity
of IIP implementation. If a patient had 10 assessments over
20 hours, the intensity of IIP implementation would be 0.5;
the intensity of IIP implementation for a patient with 20 assessments in 20 hours would be 1.0.
Significance was determined by a P value < 0.05 by univariate and multivariate analyses. Statistical analyses were
performed using SAS software, version 9.1 (SAS Institute Inc,
Cary, NC).
This study was approved by each organization’s Institutional Review Board.
Results
Group 1 comprised 79 patients. There were 20 patients
in Group 2: 10 had BG > 200 mg/dL on POD 1 only, 9
had BG > 200 mg/dL on POD 2 only, and 1 patient was
hyperglycemic both mornings. Among the approximately
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Table 1. Blood Glucose Characteristics of Study Groups

Average BG over 48 hours
Percent time with BG > 200 mg/dL
Number of episodes of BG > 200 mg/dL

Group 1: SCIP compliant*

Group 2: SCIP noncompliant*

P value

146 (15.7)
7 (10.0)
0.9 (1.0)

186 (42.6)
36 (13.9)
2.4 (1.2)

< 0.0001
< 0.0001
< 0.0001

*mean (Std Dev).
BG, blood glucose; SCIP, Surgical Care Improvement Project.

5000 BG checks measured in this study, there were 18 episodes of hypoglycemia (BG < 70 mg/dL) in 15 patients, although no patient was symptomatic of hypoglycemia.
Blood glucose characteristics of study groups
Group 1 had a lower overall mean BG compared to group
2, a lower mean BG on the IIP (147 mg/dL vs. 193 mg/dL), a
lower percent time in a hyperglycemic state, and fewer episodes of hyperglycemia over the measured 48-hour period
(P £ 0.0001 for all) (Table 1).
Furthermore, POD 1 and 2 BG were reliable metrics
reflective of overall BG in that a patient’s mean BG over the
48-hour study period was related to his POD 1 or 2 BG by
linear regression (BG mean = 0.94 [6 am BG POD 1], BG
mean = 0.96 [6 am BG POD 2]; P < 0.0001).
Factors associated with SCIP noncompliance
Both the univariate and multivariate analyses show that
Groups 1 and 2 were similar regarding age, sex, and receipt
of epinephrine infusion (Table 2). By univariate analysis,
switching to insulin SQ was a risk factor for noncompliance.
Group 2 switched to insulin SQ prior to 6 am on POD 2 more
frequently (85%) compared to group 1 (61%) (P = 0.05). Even
more striking, no patient maintained on insulin IV through
6 am on POD 2 had a BG > 200 mg/dL that morning. Specifically, 34 of 34 patients on the IIP were SCIP compliant on
POD 2, whereas only 55 of 65 patients who had switched to
insulin SQ were compliant on POD 2 (P = 0.01). Also by
univariate analysis, DM and obesity were significant risk
factors for SCIP noncompliance (P = 0.003 and P = 0.04, respectively). Of the patients with diabetes in the study, only
63% were SCIP compliant compared to 89% of nondiabetics.
Finally, in that the intensity of IIP implementation was not
different between groups, SCIP noncompliance was not the
result of provider inattention. In fact, the trend was for more
assessments in the noncompliant group. (Group 1: 0.62
assessments/hour; Group 2: 0.72 assessments/hour; P = 0.25).
By multivariate analysis, obesity ceased to be a predictor
of SCIP noncompliance, but DM and switching to insulin SQ
continued to be. Of note, by stepwise multivariate analysis, if
DM was not present, obesity then became a significant risk
factor. As with the univariate analysis, switching to insulin
SQ prior to 6 am on POD 2 continued to be a risk factor for
SCIP noncompliance. As already indicated, every patient
maintained on insulin IV was compliant on POD 2.
Discussion
The evidence of the benefit of glycemic control in postoperative cardiac surgery patients has been consistent.5,7–9,18,19 In

these studies, glycemic control has led to improved outcomes
when BG has been kept in the 150–170 mg/dL range as
compared to >200 mg/dL. Coincident with these findings
regarding BG and postoperative wound infections, it has become apparent that protocols and checklists that ‘‘force’’
physician behavior reduce medical errors and improve quality
of care,20–23 and many hospitals have instituted insulinglucose algorithms to good effect.24–33 However, our experience in instituting an IIP was less successful; in particular, as
evidenced by our inability to consistently meet the SCIP
metric of BG £ 200 mg/dL on POD 1 and 2 at 6 am. We
initially hypothesized that erratic implementation of our IIP,
which aimed for a BG of < 140 mg/dL, was responsible for
our inability to dependably prevent hyperglycemia. To the
contrary, our findings showed that poor BG control in the
SCIP noncompliant group occurred in the face of a trend toward an increased number of BG assessments. A variety of
published studies appear to mirror our experience; specifically, one uniform IIP is not effective for all patients,34–36 and
when it fails, it fails in patients with diabetes.37
The data also showed that all instances of noncompliance
on POD 2 were in patients on insulin SQ, while every patient
on insulin IV on POD 2 was compliant, regardless of risk
Table 2. Predictors of SCIP Noncompliance,
Univariate and Multivariate Models

Measurement
Age, continuous
Male
Obese
DM
Epi
Switched to Ins SQ
prior to 6 am
POD 2
IIP intensity
(checks/hour)

Univariate
Odds Ratio
(95% CI)
P value

Multivariate
Odds Ratio
(95% CI)
P value

1.003 (0.95–1.06)
0.9
1.74 ( 0.53–5.77)
0.36
2.88 (1.03–8.00)
0.04
4.81 (1.70–13.64)
0.003
1.03 (0.38–2.74)
0.96
3.66 (0.99–13.53)
0.05

1.035( 0.97–1.10)
0.29
2.304 (0.53–9.94)
0.21
3.025 (0.84–10.90)
0.07*
4.926 (1.32–18.42)
0.003
0.706 (0.17–2.89)
0.58
17.140 (2.77–105.96)
0.03

0.44 (0.1–71.10)
0.09

0.132 (0.02–0.78)
0.56

*By stepwise multivariate analysis, in the absence of DM, obesity
is a significant risk factor for SCIP noncompliance with an odds ratio
3.27, 95% confidence interval (CI) 1.05 – 10.18, P = 0.04.
DM, diabetes mellitus; Epi, epinephrine infusion; IIP, insulin
infusion protocol; Ins, insulin, SCIP, Surgical Care Improvement
Project; SQ, subcutaneous.
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factors. Interestingly, 9 of the 10 noncompliant patients on
POD 2 had diabetes and the nondiabetic patient was obese. It
seems clear from this study that transitioning patients with
DM or obesity to insulin SQ prior to POD 2 is ill advised if
hyperglycemia is to be avoided.
Although picking a moment in time to report BG measurement makes perfect sense as a metric hospitals could be
expected to report, the SCIP utilization of 6 am POD 1 and 2
BG as a surrogate for overall glycemic control is without
supporting evidence.15,16 Our paper is the first of which we
are aware to document the association between this SCIP
metric and overall glycemic control. It also is interesting to
remark that while individual 6 am BGs were highly correlated with an individual patient’s mean BG, the 6 am value is
consistently higher than the mean BG (BG mean = 0.94 [6 am
BG POD 1], BG mean = 0.96 [6 am BG POD 2]; P < 0.0001). In
that the 6 am time point represents a BG that is higher than
the patient’s mean, it becomes a more sensitive measure for
glycemic control. Further support of this SCIP metric as reflective of hyperglycemia is illustrated by the fact that during
the first 2 postoperative days, almost 40% of the time Group
2 patients were hyperglycemic. Prior studies have not looked
at this metric,2, 5 but we found it striking that the duration of
hyperglycemia was so different between the 2 groups.
Finally, we would like to highlight an issue of significant
importance that is ignored by the SCIP guidelines. By targeting a lower blood sugar, SCIP may inadvertently be increasing the incidence of hypoglycemia. In this study, 15
patients experienced BG < 70 mg/dL, the vast majority (80%)
of whom were in the SCIP compliant group. In the recent
NICE-SUGAR Study, which targeted a tightly controlled BG
of 80-110 mg/dL, investigators reported a hypoglycemia rate
of 6.8% (BG < 40 mg/dL),38 with an increased mortality in
that group related solely to the deaths in the hypoglycemic
subpopulation. Thus, while it is true that hyperglycemia in
postoperative cardiac surgery patients increases morbidity
and mortality, it is also clear that tight BG control puts patients at risk for hypoglycemia, with its own associated
morbidity and mortality.39–41 We contend that SCIP should
require concurrent reporting of hypoglycemia, an unintended consequence of BG control, as it is at least of equal if
not more importance to patient outcomes than hyperglycemia. Although none of our patients experienced hypoglycemia to the degree seen in the NICE-SUGAR Study, virtually
all of the patients who experienced BG < 70 mg/dL fell in the
SCIP compliant group. Aiming for SCIP compliance may
inadvertently make hypoglycemia an issue for this population, and safeguarding against that by requiring its report is
advisable.
We would be remiss if we did not acknowledge that SCIP
metrics have become an indicator of hospital performance
for all of us who care for surgical patients.42 Adherence to
SCIP metrics is now viewed as synonymous with quality of
care.16, 43 Publicly reporting compliance with SCIP guidelines on Web sites such as Hospital Compare.org43 is designed to help consumers make choices regarding hospitals.
Viewed in this manner, compliance with SCIP metrics has
become much more than simply an attempt to diminish
postoperative wound infections or other complications, but a
way for our hospitals to assure the public that they are being
well served. The choice of metrics required by SCIP for
public reporting is arguably even more important, when

WHITMAN ET AL.
viewed in this manner, as they no longer simply reflect
perioperative care but are much more far-reaching.
The authors recognize that a weakness of this study is
its size and retrospective design. Furthermore, recent data
show the capillary blood glucose sample may not perfectly
correlate with serum glucose levels.44,45 Yet, the findings
are significant and striking, and we feel accurately reflect
the problems hospitals face in carrying out glucose control for cardiac surgery patients in the early postoperative
period. Furthermore, during the analysis of this study, we
recognized that by emphasizing only control of hyperglycemia, SCIP may be fostering unwanted, unmeasured
morbidity in this population. Future investigation should
continue to examine improved tools to prevent hyperglycemia in postoperative patients, but with the caveat that we
must simultaneously determine to what degree hypoglycemia occurs as a result.
Conclusion
This study shows that a single uniform IIP may not be
effective to treat all intensive care unit patients, particularly
postoperative cardiac surgery patients with DM and obesity.
Furthermore, transition to insulin SQ should not occur prior
to POD 2, especially in those 2 classes of patients, as they
represent the highest risk for SCIP noncompliance. Finally,
whether by luck or by design, 6 am BG on POD 1 and 2
significantly correlates with postoperative hyperglycemia
(BG > 200 mg/dL) as measured by mean BG, percent time
> 200 mg/dL, and number of episodes > 200 mg, supporting
its use as a marker for glycemic control. Nevertheless, it is
apparent that the SCIP focus on hyperglycemia, while ignoring the incidence of hypoglycemic events, may have unintended, deleterious consequences. In this respect, our study
points out the need for continued assessment of publicly
reported metrics, to critically evaluate them as adequate
surrogates for quality of care, assuring that adherence to
them is without unintended, adverse consequences.
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